tretazicar has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CJ; Bilsland, AE; Evans, TR; Fletcher-Monaghan, AJ; Ganly, I; Keith, WN; Knox, RJ; McGregor, F; Plumb, JA | 1 |
| Bilsland, A; Evans, TR; Glasspool, RM; Kakani, R; Keith, WN; Knox, RJ; Plumb, JA; Zhao, J | 1 |
2 other study(ies) available for tretazicar and Cancer of Cervix
| Article | Year |
|---|---|
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Topics: Adenocarcinoma; Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Bacterial Proteins; Base Sequence; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasms; Nitroreductases; Ovarian Neoplasms; Promoter Regions, Genetic; Telomerase; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Topics: Animals; Aziridines; Bacteria; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Enzymologic; Genetic Therapy; Genetic Vectors; Humans; Mice; Neoplasm Transplantation; Neoplasms; Nitroreductases; Prodrugs; Promoter Regions, Genetic; Telomerase; Transgenes; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |